Search research articles
Contact Us
Filters
Showing results (31-40 of 107) with videos related to
Page
of 11
Sort By:
British Journal of Haematology
|
December 17, 2019
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature
Dikélélé Elessa, Alexis Talbot, Naëlle Lombion, et al.
ESC Heart Failure
|
November 16, 2021
Thromboembolism and bleeding in systemic amyloidosis: a review
Martin Nicol, Virginie Siguret, Giuseppe Vergaro, et al.
Kidney International
|
July 16, 2015
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease
Camille Cohen, Bruno Royer, Vincent Javaugue, et al.
British Journal of Haematology
|
April 8, 2022
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patients
Dikelele Elessa, Pierre-Edouard Debureaux, Camille Villesuzanne, et al.
Journal of Medical Virology
|
May 22, 2025
Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients
Sarah Timsit, Guillaume Mellon, Nathalie Forgeard, et al.
Frontiers in Cardiovascular Medicine
|
August 21, 2023
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
Martin Nicol, Giuseppe Vergaro, Thibaud Damy, et al.
Blood
|
August 21, 2010
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
Philippe Moreau, Arnaud Jaccard, Lotfi Benboubker, et al.
European Heart Journal. Cardiovascular Imaging
|
July 12, 2019
Diagnostic score of cardiac involvement in AL amyloidosis
Martin Nicol, Mathilde Baudet, Stephanie Brun, et al.
Hemasphere
|
June 19, 2026
CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma
Benoît Ferment, Amani Ouedrani, Alexis Talbot, et al.
Ejhaem
|
September 2, 2022
CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment
Audrey Abecassis, Nathalie Roders, Maxime Fayon, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 107) with videos related to
Sort By:
Page
of 11
British Journal of Haematology
|
December 17, 2019
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature
Dikélélé Elessa, Alexis Talbot, Naëlle Lombion, et al.
ESC Heart Failure
|
November 16, 2021
Thromboembolism and bleeding in systemic amyloidosis: a review
Martin Nicol, Virginie Siguret, Giuseppe Vergaro, et al.
Kidney International
|
July 16, 2015
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease
Camille Cohen, Bruno Royer, Vincent Javaugue, et al.
British Journal of Haematology
|
April 8, 2022
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patients
Dikelele Elessa, Pierre-Edouard Debureaux, Camille Villesuzanne, et al.
Journal of Medical Virology
|
May 22, 2025
Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients
Sarah Timsit, Guillaume Mellon, Nathalie Forgeard, et al.
Frontiers in Cardiovascular Medicine
|
August 21, 2023
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
Martin Nicol, Giuseppe Vergaro, Thibaud Damy, et al.
Blood
|
August 21, 2010
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
Philippe Moreau, Arnaud Jaccard, Lotfi Benboubker, et al.
European Heart Journal. Cardiovascular Imaging
|
July 12, 2019
Diagnostic score of cardiac involvement in AL amyloidosis
Martin Nicol, Mathilde Baudet, Stephanie Brun, et al.
Hemasphere
|
June 19, 2026
CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma
Benoît Ferment, Amani Ouedrani, Alexis Talbot, et al.
Ejhaem
|
September 2, 2022
CAR-T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment
Audrey Abecassis, Nathalie Roders, Maxime Fayon, et al.
Page
of 11